Recruiting Colorectal Cancer Studies in Commack
A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma
The purpose of this study is to find out whether the combination of botensilimab and balstilimab (BOT/BAL) is a safe and effective treatment that causes few or mild side effects for people with mismat...
A Study of Tucatinib and Trastuzumab in People With Rectal Cancer
The study researchers believe that a combination of the drugs trastuzumab and tucatinib, given with standard chemotherapy (capecitabine and oxaliplatin/FOLFOX), may help participants with rectal cance...
About Colorectal Cancer Clinical Trials in Commack
Colorectal cancer starts in the colon or rectum and is the third most common cancer diagnosed in both men and women. Early detection through screening significantly improves outcomes. Treatments include surgery, chemotherapy, radiation, and targeted therapies.
There are currently 2 colorectal cancer clinical trials recruiting participants in Commack, NEW%20YORK. These studies are seeking a combined 77 participants. Research is being sponsored by Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.
Colorectal Cancer Clinical Trials in Commack — FAQ
Are there colorectal cancer clinical trials in Commack?
Yes, there are 2 colorectal cancer clinical trials currently recruiting in Commack, NEW%20YORK. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Commack?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Commack research site will contact you about next steps.
Are clinical trials in Commack free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Commack studies also compensate for your time and travel.
What colorectal cancer treatments are being tested?
The 2 active trials in Commack are testing new therapies including novel drugs, biologics, and treatment approaches for colorectal cancer.
Data updated March 2, 2026 from ClinicalTrials.gov